Daily as of 2 Nov 16:00 ET
- Price
- above both $19.49 vs 50 $13.67 / 200 $9.36
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 9 Jul 2026 · projected 24 bars out
REPL | Replimune GroupNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$19.49
+$1.88 (+10.68%)
Replimune Group (REPL) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2019.
The 50 SMA has sat above the 200 on the daily since Jul 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits above the 50 and the 200 on the daily, the weekly and the 4-hour.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- above both $17.61 vs 50 $9.48 / 200 $11.67
- Projection
- 🟨Golden cross projected in 13 bars
- Test
- No active test
- Last cross
- 💀Death cross week of 15 Aug 2022 · projected 10 bars out
4-hour as of 3 Nov 16:00 ET
- Price
- above both $20.65 vs 50 $13.53 / 200 $12.56
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 11 Jun 2026 · projected 23 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 9 Jul 2026 | 🟨Golden steep | daily | 24 bars out | Not tested |
| 11 Jun 2026 | 🟨Golden | 4-hour | 23 bars out | Not tested |
| 8 Apr 2026 | 💀Death flat | daily | not projected | 1 bar cross test |
| 7 Apr 2026 | 🟨Golden flat | daily | 24 bars out | Not tested |
| 16 Mar 2026 | 💀Death moderate | daily | 6 bars out | 2 bar cross test |
About REPL
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$28.1M
4-hour coverageYes, since Oct 2025
History on recordSince 2019
SectorHealthcare
Cap bandsmall